GSK plc filed a Form 6-K with the U.S. Securities and Exchange Commission on November 6, 2026, disclosing provisional quarterly dividend dates for the full year 2027, including ex-dividend, record, and payment dates for both ordinary shares and American Depositary Shares.

Key Highlights

  • Four quarterly dividends scheduled: GSK disclosed provisional dividend dates for Q1, Q2, Q3, and Q4 2027, with the Q4 2027 payment date falling in April 2028.
  • Q1 2027 payable date: The first quarterly dividend is scheduled to be payable on Thursday, July 15, 2027, with a record date of Friday, May 14, 2027.
  • Q2 2027 payable date: The second quarterly dividend is scheduled to be payable on Thursday, October 14, 2027, with a record date of Friday, August 13, 2027.
  • Q3 2027 payable date: The third quarterly dividend is scheduled to be payable on Thursday, January 13, 2028, with a record date of Friday, November 12, 2027.
  • Q4 2027 payable date: The fourth quarterly dividend is scheduled to be payable on Thursday, April 13, 2028, with a record date of Friday, February 18, 2028.
  • Dates are indicative: According to the filing, "These dates are indicative and may be subject to change."

GSK 2027 Provisional Quarterly Dividend Schedule Details

GSK plc (NYSE:GSK) published its provisional dividend calendar for 2027 in a Form 6-K report for the month of November 2026, signed by Company Secretary V A Whyte on November 6, 2026. The filing sets out four sets of key dividend dates covering results announcement dates, ex-dividend dates for both ordinary shares and American Depositary Shares, record dates, last dates for Dividend Reinvestment Plan (DRIP) elections, and payable dates.

For Q1 2027, the company disclosed a results announcement date of Wednesday, April 28, 2027, an ordinary shares ex-dividend date of Thursday, May 13, 2027, an American Depositary Shares ex-dividend date of Friday, May 14, 2027, a record date of Friday, May 14, 2027, a last date for DRIP elections of Thursday, June 24, 2027, and a payable date of Thursday, July 15, 2027. For Q2 2027, the results announcement date is Wednesday, July 28, 2027, with a payable date of Thursday, October 14, 2027. For Q3 2027, the results announcement date is Wednesday, October 27, 2027, with a payable date of Thursday, January 13, 2028. For Q4 2027, the results announcement date is Wednesday, February 2, 2028, with a payable date of Thursday, April 13, 2028.

The filing explicitly notes that all disclosed dates "are indicative and may be subject to change." No dividend amounts were specified in this filing. The report was filed under Commission File Number 001-15170 and signed on behalf of GSK plc by Victoria Whyte as Authorised Signatory.

What Was Disclosed

GSK plc disclosed provisional quarterly dividend calendar dates for 2027 across four quarters, covering ex-dividend, record, DRIP election, and payment dates for both ordinary shares and American Depositary Shares, with all dates noted as subject to change.